Pharmacogenomics is the future of prescribing inpsychiatry
Pharmaceutical Journal
; 309(7964), 2022.
Article
in English
| EMBASE | ID: covidwho-2065049
neuroleptic agent; adverse drug reaction; article; coronavirus disease 2019; decision support system; drug response; drug substitution; genetic variability; genetics; genomic medicine; genotyping; health care personnel; human; mental health; pandemic; patient engagement; personalized medicine; pharmacogenetic testing; pharmacogenomics; prescription; prevalence; psychiatry; psychosis; therapy; treatment outcome; treatment response
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
Pharmaceutical Journal
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS